Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris. / Mose, T; Mathiesen, L; Karttunen, V; Nielsen, J K S; Sieppi, E; Kummu, M; Mørck, T A; Myöhänen, K; Partanen, H; Vähäkangas, K; Knudsen, L E; Myllynen, P.

In: Placenta, Vol. 33, 2012, p. 433-439.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Mose, T, Mathiesen, L, Karttunen, V, Nielsen, JKS, Sieppi, E, Kummu, M, Mørck, TA, Myöhänen, K, Partanen, H, Vähäkangas, K, Knudsen, LE & Myllynen, P 2012, 'Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris', Placenta, vol. 33, pp. 433-439. https://doi.org/10.1016/j.placenta.2012.02.004

APA

Mose, T., Mathiesen, L., Karttunen, V., Nielsen, J. K. S., Sieppi, E., Kummu, M., ... Myllynen, P. (2012). Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris. Placenta, 33, 433-439. https://doi.org/10.1016/j.placenta.2012.02.004

Vancouver

Mose T, Mathiesen L, Karttunen V, Nielsen JKS, Sieppi E, Kummu M et al. Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris. Placenta. 2012;33:433-439. https://doi.org/10.1016/j.placenta.2012.02.004

Author

Mose, T ; Mathiesen, L ; Karttunen, V ; Nielsen, J K S ; Sieppi, E ; Kummu, M ; Mørck, T A ; Myöhänen, K ; Partanen, H ; Vähäkangas, K ; Knudsen, L E ; Myllynen, P. / Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris. In: Placenta. 2012 ; Vol. 33. pp. 433-439.

Bibtex

@article{2bfcc772568543b389516c8354e1eb5c,
title = "Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris",
abstract = "In the EU integrated project NewGeneris, we studied placental transport of thirteen immunotoxic and genotoxic agents in three ex vivo placental perfusion laboratories. In the present publication, all placental perfusion data have been re-analyzed and normalized to make them directly comparable and rankable. Antipyrine transfer data differed significantly between the studies and laboratories, and therefore normalization of data was necessary. An antipyrine normalization factor was introduced making the variance significantly smaller within and between the studies using the same compound but performed in different laboratories. Non-normalized (regular) and normalized data showed a good correlation. The compounds were ranked according to their transplacental transfer rate using either antipyrine normalized AUC(120) or transfer index (TI(120)({\%})). Normalization generated a division of compounds in slow, medium and high transfer rate groups. The transfer rate differed slightly depending on the parameter used. However, compounds with passage similar to antipyrine which goes through the placenta by passive diffusion, and good recovery in media (no accumulation in the tissue or adherence to equipment) were highly ranked no matter which parameter was used. Antipyrine normalization resulted in the following ranking order of compounds according to AUC(120NORM) values: NDMA = EtOH = BPA = IQ =AA = GA = PCB180 = PhIP = AFB1 > DON = BP = PCB52 = TCDD. As the variance in all parameters within a study decreased after antipyrine normalization, we conclude that this normalization approach at least partially corrects the bias caused by the small methodological differences between studies.",
author = "T Mose and L Mathiesen and V Karttunen and Nielsen, {J K S} and E Sieppi and M Kummu and M{\o}rck, {T A} and K My{\"o}h{\"a}nen and H Partanen and K V{\"a}h{\"a}kangas and Knudsen, {L E} and P Myllynen",
note = "Copyright {\^A}{\circledC} 2012 Elsevier Ltd. All rights reserved.",
year = "2012",
doi = "10.1016/j.placenta.2012.02.004",
language = "English",
volume = "33",
pages = "433--439",
journal = "Placenta",
issn = "0143-4004",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Meta-analysis of data from human ex vivo placental perfusion studies on genotoxic and immunotoxic agents within the integrated European project NewGeneris

AU - Mose, T

AU - Mathiesen, L

AU - Karttunen, V

AU - Nielsen, J K S

AU - Sieppi, E

AU - Kummu, M

AU - Mørck, T A

AU - Myöhänen, K

AU - Partanen, H

AU - Vähäkangas, K

AU - Knudsen, L E

AU - Myllynen, P

N1 - Copyright © 2012 Elsevier Ltd. All rights reserved.

PY - 2012

Y1 - 2012

N2 - In the EU integrated project NewGeneris, we studied placental transport of thirteen immunotoxic and genotoxic agents in three ex vivo placental perfusion laboratories. In the present publication, all placental perfusion data have been re-analyzed and normalized to make them directly comparable and rankable. Antipyrine transfer data differed significantly between the studies and laboratories, and therefore normalization of data was necessary. An antipyrine normalization factor was introduced making the variance significantly smaller within and between the studies using the same compound but performed in different laboratories. Non-normalized (regular) and normalized data showed a good correlation. The compounds were ranked according to their transplacental transfer rate using either antipyrine normalized AUC(120) or transfer index (TI(120)(%)). Normalization generated a division of compounds in slow, medium and high transfer rate groups. The transfer rate differed slightly depending on the parameter used. However, compounds with passage similar to antipyrine which goes through the placenta by passive diffusion, and good recovery in media (no accumulation in the tissue or adherence to equipment) were highly ranked no matter which parameter was used. Antipyrine normalization resulted in the following ranking order of compounds according to AUC(120NORM) values: NDMA = EtOH = BPA = IQ =AA = GA = PCB180 = PhIP = AFB1 > DON = BP = PCB52 = TCDD. As the variance in all parameters within a study decreased after antipyrine normalization, we conclude that this normalization approach at least partially corrects the bias caused by the small methodological differences between studies.

AB - In the EU integrated project NewGeneris, we studied placental transport of thirteen immunotoxic and genotoxic agents in three ex vivo placental perfusion laboratories. In the present publication, all placental perfusion data have been re-analyzed and normalized to make them directly comparable and rankable. Antipyrine transfer data differed significantly between the studies and laboratories, and therefore normalization of data was necessary. An antipyrine normalization factor was introduced making the variance significantly smaller within and between the studies using the same compound but performed in different laboratories. Non-normalized (regular) and normalized data showed a good correlation. The compounds were ranked according to their transplacental transfer rate using either antipyrine normalized AUC(120) or transfer index (TI(120)(%)). Normalization generated a division of compounds in slow, medium and high transfer rate groups. The transfer rate differed slightly depending on the parameter used. However, compounds with passage similar to antipyrine which goes through the placenta by passive diffusion, and good recovery in media (no accumulation in the tissue or adherence to equipment) were highly ranked no matter which parameter was used. Antipyrine normalization resulted in the following ranking order of compounds according to AUC(120NORM) values: NDMA = EtOH = BPA = IQ =AA = GA = PCB180 = PhIP = AFB1 > DON = BP = PCB52 = TCDD. As the variance in all parameters within a study decreased after antipyrine normalization, we conclude that this normalization approach at least partially corrects the bias caused by the small methodological differences between studies.

U2 - 10.1016/j.placenta.2012.02.004

DO - 10.1016/j.placenta.2012.02.004

M3 - Journal article

C2 - 22374511

VL - 33

SP - 433

EP - 439

JO - Placenta

JF - Placenta

SN - 0143-4004

ER -

ID: 37840083